Atossa Genetics Stock Price To Earnings To Growth
ATOS Stock | USD 1.28 0.01 0.78% |
Atossa Genetics fundamentals help investors to digest information that contributes to Atossa Genetics' financial success or failures. It also enables traders to predict the movement of Atossa Stock. The fundamental analysis module provides a way to measure Atossa Genetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atossa Genetics stock.
Atossa | Price To Earnings To Growth |
Atossa Genetics Company Price To Earnings To Growth Analysis
Atossa Genetics' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Atossa Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Atossa Genetics is extremely important. It helps to project a fair market value of Atossa Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Atossa Genetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Atossa Genetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Atossa Genetics' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Atossa Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Atossa Genetics has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Atossa Genetics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Atossa Genetics from analyzing Atossa Genetics' financial statements. These drivers represent accounts that assess Atossa Genetics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Atossa Genetics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 3.0M | 4.2M | 13.3M | 10.7M | 12.4M | 16.6M | |
Enterprise Value | (4.2M) | (6.1M) | 809.6K | (28.8M) | (33.1M) | (31.5M) |
Atossa Fundamentals
Return On Equity | -0.31 | ||||
Return On Asset | -0.2 | ||||
Current Valuation | 86.26 M | ||||
Shares Outstanding | 125.8 M | ||||
Shares Owned By Insiders | 0.05 % | ||||
Shares Owned By Institutions | 28.20 % | ||||
Number Of Shares Shorted | 12.45 M | ||||
Price To Earning | (0.62) X | ||||
Price To Book | 2.19 X | ||||
EBITDA | (31.35 M) | ||||
Net Income | (30.09 M) | ||||
Cash And Equivalents | 125.54 M | ||||
Cash Per Share | 0.99 X | ||||
Total Debt | 5.24 M | ||||
Current Ratio | 35.19 X | ||||
Book Value Per Share | 0.59 X | ||||
Cash Flow From Operations | (20.94 M) | ||||
Short Ratio | 20.27 X | ||||
Earnings Per Share | (0.21) X | ||||
Target Price | 5.83 | ||||
Number Of Employees | 12 | ||||
Beta | 1.23 | ||||
Market Capitalization | 161.03 M | ||||
Total Asset | 96.25 M | ||||
Retained Earnings | (186.29 M) | ||||
Working Capital | 112.63 M | ||||
Current Asset | 4.29 M | ||||
Current Liabilities | 2.5 M | ||||
Net Asset | 96.25 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.